Public health paradoxes and the epidemiological impact of an HPV vaccine
- 1 October 2000
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 19 (1-2), 101-111
- https://doi.org/10.1016/s1386-6532(00)00129-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Bacterial Vaccines and Serotype Replacement: Lessons fromHaemophilus influenzaeand Prospects forStreptococcus pneumoniaeEmerging Infectious Diseases, 1999
- No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11International Journal of Cancer, 1999
- Natural History of Dysplasia of the Uterine CervixJNCI Journal of the National Cancer Institute, 1999
- The Influence of Behavioural Heterogeneity on the Population Level Effect of Potential Prophylactic Human Immunodeficiency Virus Type 1 VaccinesJournal of the Royal Statistical Society Series A: Statistics in Society, 1998
- Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: Sensitivity, specificity, and cost-effectivenessAmerican Journal of Obstetrics and Gynecology, 1997
- Vaccination against colonizing bacteria with multiple serotypesProceedings of the National Academy of Sciences, 1997
- Predicting the Effect of Varicella Vaccine on Subsequent Cases of Zoster and VaricellaReviews in Medical Virology, 1996
- Do Our Current Cervical Cancer Control Strategies Still Make Sense?JNCI Journal of the National Cancer Institute, 1996
- Can papilloma virus testing be used to improve cervical cancer screening?International Journal of Cancer, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995